Indian regenerative medication firm targets human trials of remedy designed to revive imaginative and prescient to sufferers with corneal opacity.
Indian biotech Pandorum Technologies has secured $11 million in a “pre-Collection B” funding spherical to advance its flagship remedy for corneal blindness into human trials. The Bengaluru-based firm, which makes a speciality of tissue engineering and regenerative medication, has developed a “liquid cornea” know-how primarily based on regenerative exosomes that’s designed to “reverse an ulcerative cornea to a wholesome state in lower than a yr.”
In keeping with Pandorum, corneal opacity accounts for over 4% of blindness worldwide, with greater than 1.5 million new circumstances annually. The corporate says its strategy has demonstrated in “in depth pre-clinical research” to advertise scarless regeneration of cornea tissue and restore imaginative and prescient.
With analysis and improvement labs in Bengaluru, India, and the Bay Space, San Francisco, Pandorum is now centered on advancing its cornea program by means of scientific manufacturing and regulatory processes, aiming to dose its first sufferers in 2025.
“Our flagship product Kuragenx combines proprietary biomaterials with regenerative nanotherapy, guiding the formation of a useful corneal tissue to revive imaginative and prescient,” stated Dr Tuhin Bhowmick, CEO of Pandorum.
Past its corneal blindness program, the funding may also facilitate the development of Pandorum’s know-how platform, which the corporate claims additionally has regenerative potential in liver, lung, and neuronal tissues.
The brand new funding was sourced from a consortium of buyers together with Everest Finance Funding, Acebright Pharma, and famend Indian buyers Ashish Kacholia and Bandana Kankani, alongside current buyers Sunil Kant Munjal and the Indian Angel Community.
“This startup is engaged on remedy for corneal blindness,” stated Kacholia. “Although the journey to commercialization is lengthy, superb payoffs potential for all mankind. Indian science and scientific group making superb strides.”
